Catalio Capital
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
Investment stages
- Seed
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Cryptocurrency
About
Catalio Capital Management focuses on investing in innovative biomedical technology firms established by prominent scientist entrepreneurs, leveraging their expertise to drive advancements in the field.
Catalio Capital Management focuses on investing in innovative biomedical technology firms established by prominent scientist entrepreneurs, leveraging their expertise to drive advancements in the field.
Investment Thesis
Catalio’s investment thesis revolves around backing companies that are developing cuttingedge drugs, devices, diagnostics, and datadriven healthcare solutions. Their Nexus private equity strategy focuses on early to latestage biomedical companies, with a commitment to working closely with founders, building strong management teams, and partnering with toptier coinvestors.
Manager's Experience
With extensive experience in private equity, the fund manager has successfully executed over 50 deals across technology, healthcare, and consumer sectors. Active primarily in North America and Europe, their strategic style emphasizes a data-driven approach, targeting growth-stage investments. Notable exits include several high-profile sales that have significantly outperformed market averages. Their operator-first philosophy ensures hands-on involvement in portfolio companies, driving transformative growth and value creation.
Team
Tom Brooks
Olly Butcher